Imunon, Inc. Annual Deferred Income Tax Expense (Benefit) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Imunon, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
  • Imunon, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $1.28M, a 18.3% decline year-over-year.
  • Imunon, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $287K.
  • Imunon, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$184K, a 140% decline from 2021.
  • Imunon, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $462K.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $287K +$470K Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$184K -$646K -140% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $462K +$489K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$26.5K +$1.79M +98.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$1.82M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.